Humans have over 70 potassium channel genes, but only some of these have been linked to disease. In this respect, the KCNQ family of potassium channels is exceptional: mutations in four out of five KCNQ genes underlie a range of diseases including cardiac arrhythmias, deafness, and epilepsy. For example, mutations in KCNQ1 are associated with heart arrhythmias such as long-QT syndrome (LQTS), in which the cardiac action potential is prolonged. Mutations in KCNQ2 and KCNQ3 are associated with benign neonatal epilepsy. Homologs of KCNQ genes are found in a wide range of model organisms, including flies and mice, where they often have functions analogous to those in humans, but less is known about the functions of these potassium channels in the nematode C. elegans. We investigated the effect of mutations in C. elegans KCNQ-like genes on the electrical excitability of the pharynx, a rhythmic muscular pump involved in feeding. One such gene,
kqt-1, is orthologous to the subfamily of human KCNQ genes that comprises KCNQ2 to KCNQ5, and is mainly expressed in the muscles of the pharynx.
kqt-3 is orthologous to the human gene KCNQ1. Although not expressed in the pharynx,
kqt-3 is present in mechanosensory and chemosensory neurons, which can regulate feeding behavior. We hypothesized that mutations in
kqt-1 and
kqt-3 induce abnormalities in pharyngeal pumping that are reminiscent of cardiac arrhythmias. Taking advantage of a new microfluidic system for C. elegans electrophysiology (NemaMetrix ScreenChip(TM)), we tested this hypothesis by measuring the duration of pharyngeal action potentials and related parameters of pharyngeal pumping. We present evidence that
kqt-1 and
kqt-3 are necessary for normal pharyngeal pumping, consistent with the well-known role of KCNQ potassium channel mutations in generating cardiac arrhythmias in humans and model organisms. Both genes are required for normal pumping frequency and pump duration, whereas
kqt-1 is also required for normal inter-pump intervals. We propose that the strains tested, as well as the recording methodology used, could be the basis of future studies to identify pharmacological agents that mitigate certain arrhythmias.